FK506-associated thrombotic microangiopathy: Report of two cases and review of the literature Review uri icon

Overview

MeSH Major

  • Immunosuppressive Agents
  • Tacrolimus
  • Thrombosis

abstract

  • TMA must be considered in organ transplant patients treated with FK506 whenever kidney function deteriorates, even in the absence of microangiopathic hemolytic anemia. Although TMA usually responds to treatment, it may, in rare cases, lead to loss of kidney function or even the patient's death.

publication date

  • February 27, 1999

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 10071024

Additional Document Info

start page

  • 539

end page

  • 44

volume

  • 67

number

  • 4